Parkwalk – First Light Fusion Successful Exit
Parkwalk, the leading EIS investor in UK University spin-out companies, is pleased to announce the exit of the majority of its holding in First Light Fusion via a successful sale to Oxford Sciences Innovation.
Parkwalk was one of the initial investors in the company when it was formed in June 2011 and has invested in subsequent funding rounds. The sale will give Parkwalk’s EIS investors a significant, double digit multiple return on their investment.
Paragraf – Parkwalk and UCEF V investment
We are delighted to announce that the University of Cambridge Enterprise Fund V and the Parkwalk Opportunities Fund have invested in £2.64m seed financing round in Paragraf, a spin-out from the University of Cambridge.
Paragraf is aiming to deliver the speculated capabilities of graphene and other two-dimensional materials to the real world.
MedaPhor – Parkwalk investment
We are delighted to announce that the Parkwalk Opportunities Fund has participated in the recent financing round of Medaphor Group plc, the Cardiff University Spin-out and global provider of advanced ultrasound training simulators for medical professionals.
PsyOmics – follow-on investment
We are delighted to announce that the University of Cambridge Enterprise Fund V and the Parkwalk Opportunities Fund have invested in a follow-on financing round in PsyOmics, a spin-out from the Department of Chemical Engineering and Biotechnology.
The company aims to utilise blood-based diagnostics to increase the speed of diagnosis and to reduce misdiagnosis for mental health patients.
Oxford Quantum Circuits – Parkwalk investment
We are delighted to announce that the Parkwalk Opportunities Fund has completed an investment in Oxford Quantum Circuits Limited. The company was founded by Professor Peter Leek, who is based at the Clarendon Laboratory Oxford, and is aiming to build a quantum computer based upon a superconducting circuit approach to forming qubits. The intention is to leverage the latest technology in this field and overcome the key challenge that has confounded researchers to-date: scaling the system up to a large number of qubits.
Ionix – Parkwalk closes follow-on investment
We are pleased to announce that the Parkwalk Opportunities EIS Fund has participated in a follow-on financing round into Ionix Advanced Technologies, a Leeds University Spin-out that has developed extreme temperature piezo technology for use in the protection of high value industrial assets. Parkwalk invested alongside existing investor IP Group plc.
The market for piezo technologies –harnessing certain material’s capacity to transform pressure into power or, alternatively, power into pressure – is already widespread and growing. The piezoelectric market is well established but applications are limited by the properties of the materials currently in use.
Inkpath – University of Oxford Innovation Fund III investment
We are delighted to announce that the University of Oxford Enterprise Fund III has completed its penultimate investment in Inkpath, a data-driven software platform aiming to be the “Fitbit for your career.”
Mind Foundry – Parkwalk closes follow-on investment
We are delighted to announce that the Parkwalk Opportunities Fund has completed a follow-on investment in Mind Foundry, an Oxford Spin-out company with technology that uses advanced machine learning algorithms to help organisations solve problems by unlocking insights hidden deep within their big data.
Inductosense – University of Bristol Enterprise Fund II investment
We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Inductosense.
Inductosense specialises in the development of compact, wireless sensors for fast, repeatable detection of cracks, corrosion or defects in structures or products.
YASA Motors – Parkwalk closes follow-on investment
We are delighted to announce that the Parkwalk Opportunities Fund has led a funding round in YASA Motors, a spin-out from the University of Oxford. The company aims to commercialise its patented technology in electric motors and generators across a range of product areas.
YASA Motors (YASA) was incorporated in 2009 to commercialise the unique motor topology developed by founder and CTO Dr Woolmer at the University of Oxford. The Yokeless And Segmented Armature design – hence YASA – allows more efficient use of key magnetic and structural materials.
Ilika plc – Financial statements for year ended 30 April 2017
11 Jul 2017
Ilika (AIM: IKA), the accelerated materials innovation company, announces its audited full-year results for the year ended 30 April 2017.
Xeros Technology Group plc – Signs 10 year contract with leading European tannery
Xeros Technology Group plc has signed a 10 year contract with Wollsdorf Leder Schmidt & Co. Ges.m.b.h (‘Wollsdorf’) to convert its re-tanning operations in Austria to use Xeros’ patented polymer technology. This contract follows the previously announced heads of terms in January 2017.
Cycle.land – University of Oxford Innovation Fund III investment
We are delighted to announce that the University of Oxford Enterprise Fund III has completed an investment in Cycle.land Limited, a company helping the move toward sustainable urban transport by creating a global peer-to-peer social marketplace on which to share bicycles. Cycle.land was supported by the Oxford University Innovation Incubator.
Creavo Medical Technologies – Parkwalk closes investment
We are pleased to announce that the Parkwalk Opportunities Fund has made an investment in Creavo Medical Technologies, a University of Leeds Spin-out company, as part of a £13.4 million fundraising.
Zegami – Parkwalk closes follow on investment
We are pleased to announce that the Parkwalk Opportunities Fund and the University of Oxford Innovation Fund III have made an investment in Zegami, an Oxford University Spin-out company, as part of a Series A investment round of equity funding.
Horizon Discovery – Parkwalk UCEF I exit
We are delighted to have generated a 2.36x return (3.37x inclusive of initial tax reliefs) for our investors on the sale of the University of Cambridge Enterprise Fund I holding in Horizon Discovery plc. The investment was held for 3.9 years and the exit was generated through a single block trade.
Predictimmune – Parkwalk closes investment
We are delighted to announce that the Parkwalk Opportunities Fund and the University of Cambridge Enterprise Fund IV have completed an investment in Predictimmune Limited, a spinout company from the University of Cambridge.
Brainomix joins forces with Boehringer Ingelheim to help save stroke victims
Oxford – An ambitious collaboration between Brainomix, an emerging British business, and Boehringer Ingelheim, one of the world’s largest drug companies, is poised to expedite and improve treatment of stroke, the second biggest killer disease in Europe.
Azul Optics – University of Bristol Enterprise Fund I investment
We are delighted to announce that the University of Bristol Enterprise Fund I, managed by Parkwalk, has invested in Azul Optics.
Parkwalk H1 2017 update
It has been a busy first half of the year at Parkwalk. Our proprietary access to deal-flow has enabled us to deploy £46.5m in the last 12 months. Deal-flow has been enhanced by our tie-up with IP Group plc, who recently raised a further £200m to co-invest in the university spin-out sector.
The combined group has net assets of £797m, third-party funds under management of more than £200m and a market capitalisation of c.£1bn.
Read More
Posted on July 17, 2017
Fund Managers Comments